Free Fillet Flap of Lower Extremity: 38 Amputations with Seven Examples of Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interfaces.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 10 2023
Historique:
medline: 23 10 2023
pubmed: 14 2 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Extremely high-level lower extremity amputations are rare procedures that require significant soft-tissue and bony reconstruction. This study describes the use of fillet flaps for oncologic reconstruction and the incorporation of targeted muscle reinnervation (TMR) and regenerative peripheral nerve interfaces (RPNIs) for chronic pain prevention. The authors performed a retrospective review of patients who underwent lower extremity fillet flaps at MD Anderson Cancer Center from January of 2004 through April of 2021. Surgical outcomes were summarized and compared. Numeric rating scale and patient-reported outcomes measures were collected. Thirty-eight fillet flaps were performed for lower extremity reconstruction. Extirpative surgery included external hemipelvectomy (42%), external hemipelvectomy with sacrectomy (32%), and supratrochanteric above-knee amputation (26%). Median defect size was 600 cm 2 , and 50% included a bony component. Twenty-one patients (55%) experienced postoperative complications, with 16 requiring operative intervention. There was an increased trend toward complications in patients with preoperative radiotherapy, although this was not significant (44% versus 65%; P = 0.203). Seven patients underwent TMR or RPNI. In these patients, the mean numeric rating scale residual limb pain score was 2.8 ± 3.4 ( n = 5; range, 0 to 4/10) and phantom limb pain was 4 ± 3.2 ( n = 6; range, 0 to 7/10). The mean Patient-Reported Outcomes Measures Information Systems T scores were as follows: pain intensity, 50.8 ± 10.6 ( n = 6; range, 30.7 to 60.5); pain interference, 59.2 ± 12.1 ( n = 5; range, 40.7 to 70.1); and pain behavior, 62.3 ± 6.7 ( n = 3; range, 54.6 to 67.2). Lower limb fillet flaps are reliable sources of bone, soft tissue, and nerve for reconstruction of oncologic amputation. TMR or RPNI are important new treatment adjuncts that should be considered during every amputation. Therapeutic, IV.

Sections du résumé

BACKGROUND
Extremely high-level lower extremity amputations are rare procedures that require significant soft-tissue and bony reconstruction. This study describes the use of fillet flaps for oncologic reconstruction and the incorporation of targeted muscle reinnervation (TMR) and regenerative peripheral nerve interfaces (RPNIs) for chronic pain prevention.
METHODS
The authors performed a retrospective review of patients who underwent lower extremity fillet flaps at MD Anderson Cancer Center from January of 2004 through April of 2021. Surgical outcomes were summarized and compared. Numeric rating scale and patient-reported outcomes measures were collected.
RESULTS
Thirty-eight fillet flaps were performed for lower extremity reconstruction. Extirpative surgery included external hemipelvectomy (42%), external hemipelvectomy with sacrectomy (32%), and supratrochanteric above-knee amputation (26%). Median defect size was 600 cm 2 , and 50% included a bony component. Twenty-one patients (55%) experienced postoperative complications, with 16 requiring operative intervention. There was an increased trend toward complications in patients with preoperative radiotherapy, although this was not significant (44% versus 65%; P = 0.203). Seven patients underwent TMR or RPNI. In these patients, the mean numeric rating scale residual limb pain score was 2.8 ± 3.4 ( n = 5; range, 0 to 4/10) and phantom limb pain was 4 ± 3.2 ( n = 6; range, 0 to 7/10). The mean Patient-Reported Outcomes Measures Information Systems T scores were as follows: pain intensity, 50.8 ± 10.6 ( n = 6; range, 30.7 to 60.5); pain interference, 59.2 ± 12.1 ( n = 5; range, 40.7 to 70.1); and pain behavior, 62.3 ± 6.7 ( n = 3; range, 54.6 to 67.2).
CONCLUSIONS
Lower limb fillet flaps are reliable sources of bone, soft tissue, and nerve for reconstruction of oncologic amputation. TMR or RPNI are important new treatment adjuncts that should be considered during every amputation.
CLINICAL QUESTION/LEVEL OF EVIDENCE
Therapeutic, IV.

Identifiants

pubmed: 36780349
doi: 10.1097/PRS.0000000000010294
pii: 00006534-990000000-01565
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

883-895

Informations de copyright

Copyright © 2023 by the American Society of Plastic Surgeons.

Références

Ephraim PL, Wegener ST, MacKenzie EJ, et al. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil. 2005;86:1910.
Ehde DM, Czerniecki JM, Smith DG, et al. Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation. Arch Phys Med Rehabil. 2000;81:1039.
Smith DG, Ehde DM, Legro MW, et al. Phantom limb, residual limb, and back pain after lower extremity amputations. Clin Orthop Relat Res. 1999;361:29–38.
Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res. 2013;6:121–136.
Steinau HU, Daigeler A, Langer S, et al. Limb salvage in malignant tumors. Semin Plast Surg. 2010;24:18–33.
Steinau HU, Ehrl H, Biemer E. Reconstructive plastic surgery in soft tissue sarcomas of the extremities. Eur J Plast Surg. 1988;11:99–108.
Van der Wey LP, Polder TW. Salvage of a through-knee amputation level using a free fillet of sole flap. Microsurgery 1993;14:605–607.
Tran NV, Evans GR, Kroll SS, et al. Free filet extremity flap: indications and options for reconstruction. Plast Reconstr Surg. 2000;105:99–104.
Kiiski J, Laitenen MK, Le Nail LR, et al. Soft tissue reconstruction after pelvic amputation: the efficacy and reliability of the free fillet flap reconstruction. J Plast Reconstr Aesth Surg. 2021;74:987.
Ver Halen JP, Yu P, Skoracki RJ, Chang DW. Reconstruction of massive oncologic defects using free fillet flaps. Plast Reconstr Surg. 2010;125:913–922.
Kuntscher MV, Erdmann D, Homann HH, Steinau HU, Levin SL, Germann G. The concept of fillet flaps: classification, indications, and analysis of their clinical value. Plast Reconstr Surg. 2001;108:885–896.
Morey TE, Giannoni J, Duncan E, et al. Nerve sheath catheter analgesia after amputation. Clin Orthop Relat Res. 2002;397:281.
Brooks AD, Gold JS, Graham D, et al. Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Ann Surg Oncol. 2002;9:41–47.
Dhillon GS, Kruger TB, Sandhu JS, Horch KW. Effects of short-term training on sensory and motor function in severed nerves of long-term human amputees. J Neurophysiol. 2005;93:2625–2633.
Prantl L, Schreml S, Heine N, et al. Surgical treatment of chronic phantom limb sensation and limb pain after lower limb amputation. Plast Reconstr Surg. 2006;118:1562.
Cheesborough JE, Souza JA, Dumanian GA, Bueno RA. Targeted muscle reinnervation in the initial management of traumatic upper extremity amputation injury. Hand 2014;9:253.
Bowen JB, Ruter D, Wee C, West J, Valerio IL. Targeted muscle reinnervation technique in below-knee amputation. Plast Reconstr Surg. 2019;143:309–312.
Agnew SP, Schultz AE, Dumanian GA, Kuiken TA. Targeted reinnervation in the transfemoral amputee: a preliminary study of surgical technique. Plast Reconstr Surg. 2012;129:187–194.
Fracol ME, Janes LE, Ko JH, Dumanian GA. Targeted muscle reinnervation in the lower leg: an anatomical study. Plast Reconstr Surg. 2018;142:541e–550e.
Mioton LM, Dumanian GA. Targeted muscle reinnervation and prosthetic rehabilitation after limb loss. J Surg Oncol. 2018;118:807–814.
Kuiken TA, Barlow AK, Hargrove LJ, Dumanian GA. Targeted muscle reinnervation for the upper and lower extremity. Tech Orthop. 2017;32:109–116.
Gart MS, Souza JM, Dumanian GA. Targeted muscle reinnervation in the upper extremity amputee: a technical roadmap. J Hand Surg Am. 2015;40:1877–1888.
Ursu DC, Urbanchek MG, Nedic A, Cederna PS, Gillespie RB. In vivo characterization of regenerative peripheral nerve interface function. J Neural Eng. 2016;13:026012.
Woo SL, Kung TA, Brown DL, Leonard JA, Kelly BM, Cederna PS. Regenerative peripheral nerve interfaces for the treatment of postamputation neuroma pain: a pilot study. Plast Reconstr Surg Glob Open 2016;4:1038e.
Hooper RC, Cederna PS, Brown DL, et al. Regenerative peripheral nerve interfaces for the management of symptomatic hand and digital neuromas. Plast Reconstr Surg Glob Open 2020;8:e2792.
Dellon AL, MacKinnon SE. Treatment of the painful neuroma by neuroma resection and muscle reimplantation. Plast Reconstr Surg. 1986;77:427–438.
Ducic I, Mesbahi AN, Attinger CE, Graw K. The role of peripheral nerve surgery in the treatment of chronic pain associated with amputation stumps. Plast Reconstr Surg. 2008;121:908–914.
Valerio IL, Dumanian GA, Jordan SW, et al. Preemptive treatment of phantom and residual limb pain with targeted muscle reinnervation at the time of major limb amputation. J Am Coll Surg. 2019;228:217.
Dumanian GA, Potter BK, Mioton LM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg. 2019;270:238–246.
Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop Relat Res. 2014;47:2984.
Alexander JH, Jordan SW, West JM, et al. Targeted muscle reinnervation in oncologic amputees: early experience of a novel institutional protocol. J Surg Oncol. 2019;120:348–358.
Kubiak CA, Kemp SW, Cederna PS, Kung TA. Prophylactic regenerative peripheral nerve interfaces to prevent postamputation pain. Plast Reconstr Surg. 2019;144:421e.
PROMIS. Intro to PROMIS. Available at: http://nihpromis.org/measures/instrumentoverview . Accessed October 10, 2019.
Cave EF, Rowe CR. Utilization of skin from deformed and useless fingers to cover defects in the hand. Ann Surg. 1947;125:126.
Bunnell S. Injuries of the hand. In: Surgery of the Hand. 2nd ed. Philadelphia: JB Lippincott; 1948:612.
Peacock EE Jr. Reconstruction of the hand by local transfer of composite tissue island flaps. Plast Reconstr Surg. 1960;25:298–311.
Hammond DC, Matloub HS, Kadz BB, Yousif NJ, Sanger JR, Larson DL. The free fillet flap for reconstruction of the upper extremity. Plast Reconstr Surg. 1994;94:507–512.
Kreutz-Rodrigues L, Weissler JM, Carlsen BT, et al. Reconstruction of complex hemipelvectomy defects: a 17-year single-institutional experience with lower extremity free and pedicled fillet flaps. Plast Reconstr Surg Glob Open 2020;73:242–254.
Kreutz-Rodrigues L, Mohan AT, Moran SL, et al. Extremity free fillet flap for reconstruction of massive oncologic resection: surgical technique and outcomes. J Surg Oncol. 2020;121:465–473.
Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics, and relationship to pre-amputation pain. Pain 1985;21:267–278.
Melzack R, Coderre TJ, Katz J, Vaccarino AL. Central neuroplasticity and pathologic pain. Ann N Y Acad Sci. 2001;933:157.
Flor H, Nikolajsen L, Staehelin Jensen T. Phantom limb pain: a case of maladaptive CNS plasticity? Nat Rev Neurosci. 2006;7:873–881.
Ghali S, Harris PA, Khan U, Pearse M, Nanchahal J. Leg length preservation with pedicled fillet of foot flaps after traumatic amputation. Plast Reconstr Surg. 2005;115:498–505.
Flurry M, Melissinos EG, Livingston CK. Composite forearm free fillet flaps to preserve stump length following traumatic amputations of the upper extremity. Ann Plast Surg. 2008;60:391–394.
Beck LA, Einertson MJ, Winemiller MH, DePompolo RW, Hoppe KM, Sim FF. Functional outcomes and quality of life after tumor-related hemipelvectomy. Phys Ther. 2008;88:916–927.
Houdek MT, Kralovec ME, Andrews KL. Hemipelvectomy: high-level amputation surgery and prosthetic rehabilitation. Am J Phys Med Rehabil. 2014;93:600–608.
Cuoto AG, Araujo B, Torres de Vasconcelos RA, et al. Survival rate and perioperative data of patients who have undergone hemipelvectomy: a retrospective case series. World J Surg Oncol. 2016;14:255.
Guo Y, Fu J, Palmer JL, Hanohano J, Cote C, Bruera E. Comparison of postoperative rehabilitation in cancer patients undergoing internal and external hemipelvectomy. Arch Phys Med Rehabil. 2011;92:620–625.
Mioton LM, Dumanian GA, Fracol ME, et al. Benchmarking residual limb pain and phantom limb pain in amputees through a patient-reported outcomes survey. Plast Reconstr Surg Glob Open 2020;8:e2977.
Askew AL, Cook KF, Revicki DA, et al. Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior. J Clin Epidemiol. 2016;73:103.
Witter JP. Series: clinical validity of PROMIS measures across several chronic conditions. Introduction: PROMIS a first look across diseases. J Clin Epidemiol. 2016;73:128–134.
Anderson SR, Wimalawansa SM, Roubaud MS, et al. Targeted muscle reinnervation following external hemipelvectomy or hip disarticulation: an anatomic description of technique and clinical case correlates. J Surg Oncol. 2020;122:1693–1710.
Valerio IL, Larsen M, Eberlin KR. Application of spare parts in combination with targeted muscle reinnervation surgery. Plast Reconstr Surg. 2021;147:279.

Auteurs

Margaret Roubaud (M)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

Malke Asaad (M)

Department of Plastic Surgery, University of Pittsburgh Medical Center.

Jun Liu (J)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

Alexander Mericli (A)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

Sahil Kapur (S)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

David Adelman (D)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

Matthew Hanasono (M)

From the Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH